Platform
Features
Excision BioTherapeutics
Contact
Michael Marks is on the Board of Business Advisory at Excision BioTherapeutics.
Links
30 members
Combined Therapeutics
Kymab
InterVenn Biosciences
Novozymes OneHealth
PrecisionLife